BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of July 16, 2026, BCAB trades at $4.23 with a market cap of $7.07M and a P/E ratio of -0.79. BCAB moved -8.22% today. Year to date, BCAB is -85.94%; over the trailing twelve months it is -79.27%. Its 52-week range spans $3.12 to $87.00. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BCAB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $4.23 |
| Market Cap | $7.07M |
| P/E Ratio | -0.79 |
| EPS | $-4.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $87.00 |
| 52-Week Low | $3.12 |
| Volume | 23.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $-50.62M |
| Gross Margin | 0.00% |
BCAB analyst coverage data. Average price target: $0.00.